Last update :
19/11/2024
Research teams - Genentech, Inc   pdf  
United States of America
Pharmaceutical laboratory
Genentech, Inc
San Francisco
References   References   (5)  
1
Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags
Hui A, Yin J, Liu W, Zheng K. (zheng.kai@gene.com)
Int J Pharm Compound - 2021 - ;25,3:246-257
2
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration.
Kwong Glover Z.W, Gennaro L, Yadav S, Demeule B, Wong P.Y, Sreedhara A. (sreedhaa@gene.com))
J Pharm Sci - 2012 - ; DOI 10.1002 / jps.23403
3
in vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz, Y.K. , Joyce, M., Lam, X. (lentz.yvonne@gene.com)
AAPS Pharm Sci - 2011 - ; 15, 2 : 264-272.
4
In vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz Y.K, Joyce M, Lam X. ()
Hemodial Int - 2011 - ; 15, 2 : 364-272.
5
Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy.
Lam XM, Ward CA, de C du M?e CPR. ()
Am J Health-Syst Pharm - 1995 - ; 52: 1904-1909.

List of drugs   Molecules studied   (13)  
Thrombolytic injection Alteplase
Anticancer drug injection Atezolizumab
Cardiotonic injection Dobutamine hydrochloride
Cardiotonic injection Dopamine hydrochloride
Anticoagulant injection Heparin sodium
Local anesthetic injection Lidocaine hydrochloride
Anti-arrhythmic injection Metoprolol tartrate
Analgesic injection Morphine sulfate
Vasodilator injection Nitroglycerin
Anticancer drug injection Pertuzumab
Beta-blocker injection Propranolol hydrochloride
Thrombolytic injection Tenecteplase
Anticancer drug injection Trastuzumab

  Mentions Légales